Ablynx Banks $200M IPO in Nasdaq Debut Post author:Sam Post published:October 24, 2017 Post category:BioPharma Ablynx announced the price of its U.S. IPO at $17.50. Source: BioSpace You Might Also Like Janssen to Terminate Simeprevir License With Medivir, Effective June 2018 December 10, 2017 Booming Bay Area Biotechs' Huge Headache: Where to House Their Employees October 12, 2017 5 Smaller Biotechs That are Flying Under-the-Radar December 6, 2017
